Golocdacimab

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameGolocdacimab
Drug Alias NameMEDI-6570
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionOxidized low-density lipoprotein receptor 1 inhibitors
TargetsOxidized low-density lipoprotein receptor 1
Therapy Area/IndicationsCoronary Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedimmune
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsCoronary Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A